Tay-Sachs disease is a rare inherited disorder that progressively destroys neurons in the brain and spinal cord which typically begins during infancy. Tay-Sachs disease is caused by a mutation in the HEXA gene and it is inherited in an autosomal recessive pattern. Tay-Sachs disease is also called Gangliosidosis (GM2) type 1 or Hexosaminidase A deficiency and only 1 in 300 people is a carrier for Tay-Sachs disease. There is no cure for Tay-Sachs disease, however, treatment includes targeting and controlling some of the symptoms - such as providing anticonvulsants to control seizures and proper nutrition and hydration and other comfort measures. Age of death for infants who contract Tay-Sachs disease in typically between 2 and 4 years. Tay-Sachs disease is rare in the general population and the genetic mutations that cause this disease are more common in people of Ashkenazi (eastern and central European) Jewish heritage than in those with other backgrounds.
Tay-sachs Disease Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Tay-sachs Disease below!
For more information on how to use Laverne, please read the How to Guide.
We have 510 products for the study of Tay-sachs Disease that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.